A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade

Authors

  • Naysa Gabrielly Alves de Andrade Universidade de Rio Verde
  • Ana Carolina Oliveira Universidade de Rio Verde - Campus Rio Verde
  • Bárbara de Oliveira Baptista Savariego Universidade Nilton Lins
  • Bianca Mayara Sampaio de Araújo Universidade Nilton Lins
  • Fabrício Augusto Rodrigues de Castro Médico pela Universidade Estadual de Montes Claros - Unimontes
  • Guilherme Oliveira de Azevedo Universidade Nilton Lins
  • Jessica de Oliveira Coimbra Universidade Nilton Lins
  • Manoella Lorena Arruda da Silva Cabral Chaves Centro Universitário FAMETRO
  • Maria Zilda Pereira de Araújo Médica pela Universidade Nilton Lins
  • Orisson de Steffani Basso Médico pela UNIGRANRIO - RJ
  • Rafael Rocha Gonçalves Médico pelo Instituto de Ciências da Saúde - ICS Funorte
  • Sophia de Souza Alves Maia Faculdade Metropolitana de Manaus (FAMETRO)

DOI:

https://doi.org/10.36557/2674-8169.2024v6n4p1200-1216

Keywords:

Transtorno do Déficit de Atenção e Hiperatividade, Ácidos Graxos Ômega-3, Neurodesenvolvimento, Suplementação Dietética

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurobehavioral disorder, impacting both children and adults. This integrative review highlights the importance of omega-3 fatty acids, especially EPA and DHA, in brain health and ADHD management.

 

The reviewed literature emphasizes the crucial role of diet in brain development, with adequate omega-3 intake associated with improved cognitive and behavioral function. Clinical studies demonstrate that omega-3 supplementation can reduce ADHD symptoms, especially hyperactivity, impulsivity, and inattention.

 

While omega-3 supplementation offers promising benefits for ADHD management, questions regarding dosage and treatment duration are still debated. While some recommendations suggest specific doses for pregnant and lactating women, there are variations in international guidelines. Additionally, the effectiveness of supplementation appears to depend on the dose and ratio of EPA and DHA administered.

 

Therefore, although the findings presented in this review offer valuable insights for clinical practice, further research is needed to establish clear dosage and treatment duration guidelines. This highlights the importance of an individualized approach in the diagnosis and treatment of ADHD, considering the potential benefits of omega-3 supplementation.

Downloads

Download data is not yet available.

References

CHANG, Jane Pei-Chen et al. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. Translational Psychiatry, [s. l.], 2019. DOI 10.1038/s41398-019-0633-0. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864068/. Acesso em: 4 mar. 2024.

DINICOLANTONIO, James J; O'KEEF, James H. The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders. Nutrients, [s. l.], 4 jul. 2020. DOI https://doi.org/10.3390/nu12082333. Disponível em: https://www.mdpi.com/2072-6643/12/8/2333. Acesso em: 9 abr. 2024.

HANDEL, Mina Nicole et al. Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials. Nutrients, [s. l.], v. 13, 2021. DOI https://doi.org/10.3390/nu13041226. Disponível em: https://www.mdpi.com/2072-6643/13/4/1226. Acesso em: 9 abr. 2024.

LÓPEZ VICENTE, Mônica et al. Prenatal Omega-6:Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms. Journal of Pediatrics, [s. l.], v. 209, ed. 4, p. 204-211, 28 mar. 2019. DOI 10.1016/j.jpeds.2019.02.022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30929929/. Acesso em: 9 abr. 2024.

Manual diagnóstico e estatístico de transtornos mentais [recurso eletrônico] : DSM-5 / [American Psychiatric Association ; tradução: Maria Inês Corrêa Nascimento ... et al.] ; revisão técnica: Aristides Volpato Cordioli ... [et al.]. – 5. ed. – Dados eletrônicos. – Porto Alegre : Artmed, 2014.

MARTIN, San Mauro et al. Impulsiveness in children with attention-deficit/hyperactivity disorder after an 8-week intervention with the Mediterranean diet and/or omega-3 fatty acids: a randomised clinical trial. Neurologia Full English & Spanish Text, [s. l.], 2022. DOI 10.1016/j.nrleng.2019.09.009. Disponível em:

https://pubmed.ncbi.nlm.nih.gov/34656505/. Acesso em: 2 mar. 2024.

MARTINAT, Maud et al. Perinatal Dietary Polyunsaturated Fatty Acids in Brain Development, Role in Neurodevelopmental Disorders. Nutrients, [s. l.], 2021. DOI https://doi.org/10.3390/nu13041185. Disponível em: https://www.mdpi.com/2072-6643/13/4/1185. Acesso em: 9 abr. 2024.

NEVINS, Julie E H et al. Omega-3 Fatty Acid Dietary Supplements Consumed During Pregnancy and Lactation and Child Neurodevelopment: A Systematic Review. The Journal of Nutrition , [s. l.], v. 151, p. 3483-3494, 2021. DOI https://doi.org/10.1093/jn/nxab238. Disponível em: https://www.sciencedirect.com/science/article/pii/S0022316622004114?via%3Dihub. Acesso em: 9 abr. 2024.

NOGUEIRA-DE-ALMEIDA, Carlos Alberto et al. International Journal of Nutrology (2022)Page 1 of 26II Consensus of the Brazilian Nutrology Association on DHA recommendations during pregnancy, lactation and childhood. International Journal of Nutrology, [s. l.], v. 15, 24 ago. 2022. DOI https://doi.org/10.54448/ijn22302. Disponível em: https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/237/227. Acesso em: 10 abr. 2024.

Published

2024-04-12

How to Cite

Alves de Andrade, N. G., Oliveira, A. C., de Oliveira Baptista Savariego, B., Sampaio de Araújo , B. M., Rodrigues de Castro, F. A., Oliveira de Azevedo , G., de Oliveira Coimbra, J., Arruda da Silva Cabral Chaves, M. L., Pereira de Araújo, M. Z., de Steffani Basso, O., Rocha Gonçalves, R., & de Souza Alves Maia, S. (2024). A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade. Brazilian Journal of Implantology and Health Sciences, 6(4), 1200–1216. https://doi.org/10.36557/2674-8169.2024v6n4p1200-1216